Advances of Research on Anti-HIV Agents from Traditional Chinese Herbs

2011 ◽  
Vol 23 (1) ◽  
pp. 67-75 ◽  
Author(s):  
Y. Chu ◽  
H. Liu

The current approach for dealing with the global pandemic of AIDS focuses on pharmaceuticals. The classic treatment of AIDS is highly active antiretroviral therapy, but most people living with HIV/AIDS—especially those in developing countries—have little or no access to the treatment because of the high cost of the therapy. Such treatment is associated with toxic side effects and drug resistance. As such, the search for better anti-HIV agents continues, with much attention focused on natural sources—particularly, plant species. Thousands of herbs have been screened for anti-HIV activity, and new compounds have been discovered from the extracts, many of which demonstrate inhibitory activity against HIV. Their mechanisms of action include inhibiting the activities of reverse transcriptase, protease, and integrase; weakening infection at the level of viral entry; and downregulating related gene expression. This provides researchers with new clues to synthesize drugs for the anti-HIV battle. Some synthetic derivatives of the anti-HIV natural products have stronger inhibitory effects in vitro than do their natural counterparts. Various mixed preparations of these anti-HIV herbs are in clinical trials or are applied in the treatment of people living with HIV/AIDS—some of which yield lower plasma viral load, enhance immune function, relieve related symptoms and signs, improve the quality of life, or, in combination with highly active antiretroviral therapy, alleviate the side effects of biomedical drugs. This article reviews current laboratory findings and clinical trials of anti-HIV agents from traditional herbs—particularly, herbs in traditional Chinese medicine. Drug interactions with highly active antiretroviral therapy and criteria for clinical evaluation of traditional Chinese medicine treatment are also discussed.

2020 ◽  
Author(s):  
Abere Woretaw Azagew ◽  
Chilot Kassa Mekonnen ◽  
Abebaw Jember Ferede ◽  
Kassahun Gebeyehu Yazew ◽  
Zewdu Baye Tezera

Abstract Background: Adherence to highly active antiretroviral therapy (HAART) is a public health challenge worldwide. Non-adherence to HAART leads to treatment, immunologic, and virological failure. Despite different interventions made, adherence to HAART among adult people living with HIV (PLWHIV) is still inconsistent across studies, and the effect of serostatus disclosure on adherence to HAART was not studied in Ethiopia. Therefore, the study is aimed to determine the pooled prevalence of adherence to HAART and its relationship with serostatus disclosure among adult PLWHIV in Ethiopia.Methods: We searched 3247 original articles, both published and unpublished on Ethiopia dated from January 2016 to November 2019 by using different search engines. Data were extracted using Microsoft excel. New Castle Ottawa Scale quality assessment tool was used. STATA software version 11 was used for analysis. A random-effects model for meta-analysis was computed. Cochran Q statistics and I2 were used to estimate heterogeneity. Egger’s and Begg’s test was used to assess the publication bias.Results: A total of fifteen articles for systematic review and four articles for meta-analysis were used. The pooled prevalence of adherence to HAART is found to be 81.19% (80.1, 82.3). In the subgroup analysis, the pooled prevalence of adherence to HAART was 79.82% (73.19, 86.45) in the Oromia region, 82.51 %( 73.14, 91.87) in the Amhara region, and 72.7% (63.78, 81.61) in the Southern Nations Nationalities and Peoples’ Region (SNNPR). The serostatus disclosure improves adherence to HAART by nearly three times compared to non-serostatus disclosed PLWHIV (AOR=2.99, 95 %CI: 1.88, 4.77).Conclusions: The pooled prevalence of adherence to HAART among adult PLWHIV in Ethiopia was found to be low compared to WHO antiretroviral treatment recommendations. Having serostatus disclosure improved adherence to HAART.


2018 ◽  
Vol 4 (1) ◽  
pp. 43-52
Author(s):  
David Ufuoma Adje ◽  
Felicia Esemekiphorar Williams ◽  
Chukwuka Nicholas Bezugbe ◽  
Dauda Audi Dangiwa

Background:       Adherence to Highly Active Antiretroviral Therapy (HAART) is critical in achieving treatment goals, avoiding antimicrobial resistance, preventing treatment failure and improving the patient’s quality of life. Objectives: To assess the knowledge of antiretroviral therapy (ART) and adherence to antiretroviral (ARVs) medicines amongst People Living With HIV/AIDS (PLWHA) accessing care in two Nigerian Military HIV/AIDS Treatment sites. Methods: Four hundred patients on HAART who visited the study sites during the study period were recruited for the study using systematic random sampling method. A semi-structured, pretested, interviewer-administered questionnaire was used to obtain demographic details. Patients’ knowledge of HIV was assessed using an 8-item questionnaire while adherence was measured using the Simplified Medication Adherence Questionnaire (SMAQ). Results: The predominant age group was 31-40 years (46.4%). There were more females (69%) than males (31%). Only 45.5% answered knowledge questions correctly. The adherence level in this study was 64.0%. The major reasons cited for non-adherence included being away from home (23.6%), forgetfulness (17.1%), busy schedule (14%), need to conceal medication (12.7%) and feeling better (11.6%). Conclusion: Patients’ knowledge of ART and adherence to ARVs medicines were sub-optimal. Appropriate strategies to improve patients’ knowledge of ART and adherence to ARVs are recommended.


2016 ◽  
Vol 2016 ◽  
pp. 1-10 ◽  
Author(s):  
Bonaventura C. T. Mpondo

Globally there is an increase in the number of people living with HIV at an advanced age (50 years and above). This is mainly due to prolonged survival following the use of highly active antiretroviral therapy. Living with HIV at an advanced age has been shown to be associated with a number of challenges, both clinical and immunological. This minireview aims at discussing the challenges encountered by elderly HIV-infected patients.


Sign in / Sign up

Export Citation Format

Share Document